SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.439
AS - Asia 7.417
EU - Europa 3.957
SA - Sud America 1.160
AF - Africa 167
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.150
SG - Singapore 2.735
CN - Cina 1.925
BR - Brasile 912
VN - Vietnam 900
DE - Germania 891
UA - Ucraina 756
HK - Hong Kong 610
IT - Italia 485
TR - Turchia 458
GB - Regno Unito 408
FI - Finlandia 252
SE - Svezia 242
FR - Francia 239
RU - Federazione Russa 214
JP - Giappone 188
PL - Polonia 159
IN - India 139
CA - Canada 135
MX - Messico 122
BD - Bangladesh 93
AR - Argentina 86
ID - Indonesia 74
NL - Olanda 64
ZA - Sudafrica 62
IQ - Iraq 53
BE - Belgio 48
ES - Italia 46
EC - Ecuador 45
PK - Pakistan 37
CZ - Repubblica Ceca 34
MA - Marocco 30
UZ - Uzbekistan 30
CO - Colombia 29
VE - Venezuela 26
CL - Cile 22
PH - Filippine 21
SA - Arabia Saudita 21
LT - Lituania 20
KE - Kenya 18
MY - Malesia 18
PY - Paraguay 18
IE - Irlanda 15
TN - Tunisia 15
AT - Austria 14
NP - Nepal 13
IR - Iran 12
JO - Giordania 12
UY - Uruguay 12
TW - Taiwan 11
AU - Australia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
PT - Portogallo 9
CR - Costa Rica 8
EG - Egitto 8
PE - Perù 8
RO - Romania 8
AL - Albania 6
AZ - Azerbaigian 6
CH - Svizzera 6
DZ - Algeria 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
ET - Etiopia 5
JM - Giamaica 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
EU - Europa 4
GR - Grecia 4
LV - Lettonia 4
PA - Panama 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
LB - Libano 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
LK - Sri Lanka 2
MK - Macedonia 2
MT - Malta 2
NI - Nicaragua 2
PR - Porto Rico 2
QA - Qatar 2
SI - Slovenia 2
Totale 26.133
Salva come PNG Salva come JPEG
Città #
Singapore 1.699
Ashburn 1.338
Fairfield 1.044
Woodbridge 1.044
Chandler 780
Jacksonville 773
Houston 768
San Jose 734
Ann Arbor 622
Santa Clara 599
Hong Kong 594
Beijing 565
Seattle 443
Wilmington 409
Cambridge 378
Dallas 338
Ho Chi Minh City 293
Izmir 259
Nanjing 244
Munich 218
Hanoi 212
Los Angeles 208
New York 208
Tokyo 181
Boardman 179
Princeton 171
Warsaw 150
Lauterbourg 143
The Dalles 139
Ferrara 136
San Diego 110
São Paulo 95
Buffalo 94
Milan 88
Mexico City 86
Shanghai 83
Orem 76
Council Bluffs 73
Nanchang 70
Shenyang 69
Dearborn 63
Bremen 62
Tianjin 62
Hebei 57
Helsinki 57
London 57
Turku 54
Hefei 52
Frankfurt am Main 46
Brussels 45
Düsseldorf 45
Montreal 45
San Mateo 45
Jakarta 44
Jiaxing 44
Changsha 43
Toronto 41
Chennai 40
Falkenstein 38
Falls Church 38
Da Nang 37
Haiphong 36
Brooklyn 34
Chicago 34
Jinan 34
Johannesburg 33
Moscow 33
Amsterdam 31
Denver 31
Kunming 31
Addison 28
Norwalk 28
Redwood City 28
Rio de Janeiro 28
Tashkent 28
Brno 27
Manchester 27
Belo Horizonte 26
San Francisco 25
Guangzhou 24
Rome 24
Stockholm 24
Baghdad 23
Atlanta 22
Auburn Hills 22
Boston 22
Des Moines 21
Nuremberg 21
Zhengzhou 20
Biên Hòa 19
Mountain View 19
Curitiba 18
Hải Dương 18
Bắc Ninh 16
Mumbai 16
Ningbo 16
Augusta 15
Hangzhou 15
Nairobi 15
Poplar 15
Totale 17.675
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 346
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 315
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 291
Hemostasis biomarkers in multiple sclerosis 255
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 248
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 245
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 244
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 244
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 241
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 241
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 238
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 235
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 234
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 233
Membrane binding and anticoagulant properties of protein S natural variants 229
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 224
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 221
c-myc oncogene alterations in human thyroid carcinomas. 217
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 214
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 212
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 206
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 204
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 203
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 203
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 202
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 198
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 197
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 194
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 194
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 193
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 191
Plasma levels of soluble NCAM in multiple sclerosis 190
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 187
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 187
Partial gene deletion in a family with factor X deficiency 187
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 186
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 185
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 185
alpha-Thalassemia trait in the region of Ferrara. 185
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 185
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 184
Factor VII mutant V154G models a zymogen-like form of factor VIIa 183
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 182
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 182
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 181
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 181
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 181
Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene 180
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 177
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 175
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 175
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 175
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 173
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 173
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 173
Taqi polymorphism at the human coagulation factor XII locus (F12) 172
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 171
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 169
Two taqI RFLPs in the human von willebrand factor gene 168
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 168
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 165
Localization of cloned human DNA sequences and analysis of chromosomal alteration by in situ hybridization 165
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 164
Two additional TaqI RFLPs in von willebrand factor gene (VWF) and pseudogene 164
Detection and characterization of polymorphic markers in the factor-VII gene. 162
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 162
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 162
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 161
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 161
Molecular genetics and biology of congenital hemorrhagic diseases 160
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 159
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 158
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 158
The Gly331Ser mutation in factor VII in Europe and the Middle East 157
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 157
A HIND III RFLP AND A GENE LESION IN THE COAGULATION FACTOR-VIII GENE 157
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 155
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 154
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 154
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 154
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 152
Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma 150
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 150
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 150
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 149
Hemostasis gene expression of the internal jugular and saphenous veins 149
Risks factors for highly unstable response to oral anticoagulation: a case-control study 148
Alterazione genica "de novo" in una variante della malattia di von Willebrand. 147
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 146
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 146
Clinical picture and management of congenital factor VII deficiency 145
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 145
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 145
Non-conventional therapeutic strategies for inherited disorders of hemostasis 144
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 144
A FREQUENT FACTOR-XII GENE MUTATION IN HAGEMAN TRAIT 144
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 144
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 143
β+-thalassaemia in the Po river delta region (northern Italy): Genotype and β globin synthesis 142
Decay of β-globin synthesis in heterozygous β 0 Ferrara thalassaemia 141
Totale 18.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.027
Totale 113.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021754 0 0 0 0 0 0 0 0 0 320 313 121
2021/20221.826 115 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/20253.496 93 66 295 99 468 299 78 173 507 479 536 403
2025/20269.556 974 410 1.066 1.331 1.495 707 1.306 507 941 819 0 0
Totale 26.367